Medications for Severe Asthma in the Emergency Room
For patients presenting with severe asthma to the emergency room, immediate treatment should include oxygen therapy (40-60%), nebulized beta-agonists (salbutamol 5 mg or terbutaline 10 mg), systemic corticosteroids (prednisolone 30-60 mg or IV hydrocortisone 200 mg), and ipratropium bromide 0.5 mg for severe cases. 1, 2
Initial Assessment of Severity
- Assess for features of severe asthma: inability to complete sentences in one breath, respiratory rate >25/min, pulse >110/min, and peak expiratory flow (PEF) <50% of predicted 1
- Look for life-threatening features: silent chest, cyanosis, feeble respiratory effort, bradycardia, hypotension, exhaustion, confusion, or coma 1
- Measure oxygen saturation and PEF to objectively assess severity 1, 3
First-Line Medications
- Oxygen therapy: Administer 40-60% oxygen in all cases of severe asthma 1
- Beta-agonists: Give nebulized salbutamol 5 mg or terbutaline 10 mg via oxygen-driven nebulizer 1
- Systemic corticosteroids: Administer early in treatment 2
Additional Medications for Severe Cases
- Ipratropium bromide: Add 0.5 mg to nebulized beta-agonist for severe exacerbations 1, 2
- Aminophylline: Consider 250 mg administered intravenously over 20 minutes for life-threatening features 1
- Use with caution if patient is already taking theophyllines 1
- Epinephrine (adrenaline): Reserved for catastrophic, sudden severe asthma when other treatments have failed 2
- Administer 0.5 mg via subcutaneous injection 2
Medication Administration Considerations
- Beta-agonists can be administered by continuous nebulization (CN) or bolus nebulization (BN) with equal efficacy 6
- Standard dosing of albuterol (2.5 mg) every 20 minutes is as effective as higher doses (7.5 mg) for most patients 7
- Pressurized metered-dose inhalers (pMDI) with spacers can be as effective as nebulizers when used with appropriate dosing schemes 8
- Monitor for paradoxical bronchospasm with beta-agonists, which can be life-threatening and requires immediate discontinuation 9
Monitoring Response and Follow-up
- Reassess 15-30 minutes after nebulizer treatment 1
- If signs of acute severe asthma persist:
- For patients with improving symptoms but PEF still 50-75% of predicted:
Common Pitfalls and Caveats
- Underuse of corticosteroids is a common factor in preventable asthma deaths 1
- Physicians' subjective assessments of airway obstruction are often inaccurate; rely on objective measures like PEF 4
- Patients who subsequently require admission typically show a diminished response to the first beta-agonist administration 7
- Fatalities have been reported with excessive use of inhaled sympathomimetic drugs 9
- Patients with decreased responsiveness to initial treatment may need admission regardless of medication adjustments 7